James T. Treace, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 450,002 shares at $19.21 ($38) on 2022-03-10, disclosed to the SEC on 2022-03-14.
Open-market sale of $38 TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 450,000 | $0 | 0.0% |
| 2 | $19.21 | 2 | $38 | 100.0% |
| Total | $0.00 avg | 450,002 | $38 | 100% |
| Filing → |
| TMCI | BUY | 2024-05-30 | $130K | — | Filing → |
| TMCI | BUY | 2024-05-29 | $254K | — | Filing → |
| TMCI | BUY | 2024-05-13 | $1.0M | — | Filing → |